
WEIGHT: 58 kg
Bust: 2
1 HOUR:120$
NIGHT: +40$
Services: Toys, Cum in mouth, Massage, Cunnilingus, Games
Study to gather information about the proper dosing of the oral FXIa inhibitor BAY and to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant NOAC in patients with irregular heartbeat atrial fibrillation that can lead to heart-related complications. The purpose of this study is to try to find the best dose of the new drug BAY to give to participants and to look at how well BAY works in patients with irregular heartbeat atrial fibrillation that can lead to blood clots, stroke and other heart-related complications.
In addition researchers want to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant NOAC in patients with atrial fibrillation. This study is also done to learn how the drug in this study moves into, through and out of the body. BAY , works by blocking a step of the blood clotting process in our body and thins the blood and is a so called oral FXIa inhibitor.
Apixaban, works by reducing the production of blood clotting factors in our body and thins the blood and is a so called non-vitamin K oral anticoagulant NOAC. Thinning the blood can prevent you from blood clots which can cause a stroke. E-mail: [email protected].
Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding Phase 2 study to compare the safety of the oral FXIa inhibitor BAY to apixaban in patients with atrial fibrillation.
Share Facebook Twitter LinkedIn. Back to search results Trial Condition s : Atrial fibrillation AF Study to gather information about the proper dosing of the oral FXIa inhibitor BAY and to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant NOAC in patients with irregular heartbeat atrial fibrillation that can lead to heart-related complications. Bayer Identifier: EudraCT Number: View results Ask a Question. Key Participation Requirements sex.